Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00426
Species: Homo sapiens
Position : chr16:53800454-53801454
Year: 2015
Title: FTO Obesity Variant Circuitry and Adipocyte Browning in Humans.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: obesity
PMID:  26287746
MONDO: MONDO:0011122
Tissue: subcutaneous adipose tissue
Tissue Ontology ID: UBERON:0002190
Cell Source: primary human subcutaneous adipose progenitors
Cell Type: subcutaneous preadipocyte
Cell Ontology ID: CL:0002583
Experiment Type: Endogenous enhancer-variant validation; target-gene perturbation; cellular phenotype assay; Enhancer activity assay; Endogenous enhancer perturbation; Disease-variant functional analysis
High Throughput Method: eQTL/trans-eQTL analysis; gene-expression profiling
Low Throughput Method: CRISPR-Cas9 bidirectional single-nucleotide editing; IRX5 knockdown/overexpression; RT-qPCR; oxygen-consumption and thermogenesis assays; CRISPR-Cas9 endogenous deletion/editing; Allele-specific reporter assay
About Target Gene
Target gene : IRX5
About TF
TF name : ARID5B
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
ARID5B HDMs demethylate histones reactome 49
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_00048 chr16:53800454-53801454 subcutaneous adipose tissue preadipocyte obesity
E_00049 chr16:53800454-53801454 subcutaneous adipose tissue preadipocyte obesity
E_00425 chr16:53800454-53801454 subcutaneous adipose tissue subcutaneous preadipocyte obesity
Expression of Target Genes for the Enhancer